Ryoko Sanbe

发表

Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro: a different effect on asunaprevir versus daclatasvir and beclabuvir

H. Sakaue, Masachika Fujiyoshi, Hiroyoshi Nakamura, 2019, Journal of Human Genetics.

Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro: a different effect on asunaprevir versus daclatasvir and beclabuvir

H. Sakaue, Masachika Fujiyoshi, Hiroyoshi Nakamura, 2019, Journal of Human Genetics.